Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Beckman Coulter; CLC Bio; BGI, GT Life Sciences; Massachusetts Life Sciences Center

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The auction progress to determine who will be come the buyer of Beckman Coulter has reached a second round, according to a report from Reuters this week. According to the news organization, private equity firms have paired up in an effort to provide a winning bid, while a source said that Danaher is among the bidders.

Beckman also cancelled its scheduled presentation at the JP Morgan Healthcare Conference next week.

Reports surfaced early in December that Beckman had put itself up for sale and could fetch more than $5 billion in a deal.

CLC Bio said this week that its 2010 sales increased 64 percent year over year, though it did not disclose any details or further financial information. It noted that its 2009 sales were above $10 million for the first time.

BGI and GT Life Sciences this week said that they have completed for the first time the sequencing of the Chinese hamster ovary genome, which they believe will provide useful information that could potentially cut the cost of producing therapeutic proteins. Early access to the genome is available through BGI.

The Massachusetts Life Sciences Center said this week that it has opened the application period for the second year of its Small Business Matching Grant Program, which provides grant funding to match federal small business grants for early-stage life sciences companies in the state. MLSC said that it will make $3 million available for the program in this round.